Harvard Bioscience (HBIO) Net Equity Issued and Repurchased (2010 - 2019)

Harvard Bioscience (HBIO) has 10 years of Net Equity Issued and Repurchased data on file, last reported at -$58000.0 in Q3 2019.

• On a quarterly basis, Net Equity Issued and Repurchased fell 101.85% year-over-year to -$58000.0 in Q3 2019; TTM through Sep 2019 was -$356000.0, a 107.44% decrease from a year earlier, with the FY2018 full-year figure at $4.6 million, up 2748.12% from the prior year.
• Net Equity Issued and Repurchased for Q3 2019 stood at -$58000.0, down from $87000.0 in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for HBIO reached as high as $3.1 million in Q3 2018 and fell as low as -$421000.0 in Q1 2019.
• Historically, Net Equity Issued and Repurchased has averaged $344684.2 across 5 years, with a median of $89000.0 in 2015.
• Across the five-year window, Net Equity Issued and Repurchased soared 13187.5% in 2018 and slumped 292.24% in 2019, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $89000.0 in 2015, then grew by 14.61% to $102000.0 in 2016, then surged by 155.88% to $261000.0 in 2017, then tumbled by 86.21% to $36000.0 in 2018, then tumbled by 261.11% to -$58000.0 in 2019.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were -$58000.0 in Q3 2019, $87000.0 in Q2 2019, and -$421000.0 in Q1 2019.